Counterweight Ventures LLC Acquires 191 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Counterweight Ventures LLC increased its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,709 shares of the financial services provider’s stock after acquiring an additional 191 shares during the quarter. JPMorgan Chase & Co. comprises approximately 2.7% of Counterweight Ventures LLC’s investment portfolio, making the stock its 12th biggest holding. Counterweight Ventures LLC’s holdings in JPMorgan Chase & Co. were worth $3,766,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Wilmington Savings Fund Society FSB boosted its stake in JPMorgan Chase & Co. by 0.7% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 365,770 shares of the financial services provider’s stock worth $87,679,000 after acquiring an additional 2,618 shares during the last quarter. D Orazio & Associates Inc. raised its holdings in JPMorgan Chase & Co. by 1.7% during the 4th quarter. D Orazio & Associates Inc. now owns 6,000 shares of the financial services provider’s stock worth $1,438,000 after buying an additional 103 shares during the period. Kingsview Wealth Management LLC raised its holdings in JPMorgan Chase & Co. by 3.6% during the 4th quarter. Kingsview Wealth Management LLC now owns 122,378 shares of the financial services provider’s stock worth $29,335,000 after buying an additional 4,283 shares during the period. Apollon Wealth Management LLC raised its holdings in JPMorgan Chase & Co. by 14.0% during the 4th quarter. Apollon Wealth Management LLC now owns 140,817 shares of the financial services provider’s stock worth $33,755,000 after buying an additional 17,306 shares during the period. Finally, Apollon Financial LLC raised its holdings in JPMorgan Chase & Co. by 44.6% during the 4th quarter. Apollon Financial LLC now owns 7,093 shares of the financial services provider’s stock worth $1,700,000 after buying an additional 2,187 shares during the period. Institutional investors own 71.55% of the company’s stock.

JPMorgan Chase & Co. Trading Up 0.1 %

Shares of JPMorgan Chase & Co. stock opened at $276.61 on Monday. The firm has a 50-day moving average of $253.02 and a 200-day moving average of $232.75. The stock has a market cap of $778.74 billion, a PE ratio of 14.01, a PEG ratio of 2.94 and a beta of 1.12. JPMorgan Chase & Co. has a 52-week low of $176.15 and a 52-week high of $279.23. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.89 and a current ratio of 0.88.

JPMorgan Chase & Co. (NYSE:JPM) last posted its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share for the quarter, topping the consensus estimate of $4.03 by $0.78. JPMorgan Chase & Co. had a net margin of 20.96% and a return on equity of 16.99%. The business had revenue of $42.77 billion during the quarter, compared to analysts’ expectations of $41.90 billion. During the same quarter in the prior year, the business posted $3.04 earnings per share. JPMorgan Chase & Co.’s revenue was up 10.9% compared to the same quarter last year. As a group, sell-side analysts forecast that JPMorgan Chase & Co. will post 18.05 EPS for the current year.

JPMorgan Chase & Co. Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend was Monday, January 6th. JPMorgan Chase & Co.’s payout ratio is 25.33%.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Oppenheimer downgraded shares of JPMorgan Chase & Co. from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 20th. UBS Group lifted their price objective on shares of JPMorgan Chase & Co. from $276.00 to $287.00 and gave the company a “buy” rating in a report on Thursday, January 16th. Piper Sandler lifted their price objective on shares of JPMorgan Chase & Co. from $240.00 to $275.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Wells Fargo & Company lifted their price objective on shares of JPMorgan Chase & Co. from $240.00 to $270.00 and gave the company an “overweight” rating in a report on Friday, November 15th. Finally, Citigroup boosted their target price on shares of JPMorgan Chase & Co. from $215.00 to $250.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $251.78.

Insiders Place Their Bets

In other JPMorgan Chase & Co. news, General Counsel Stacey Friedman sold 3,303 shares of the business’s stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of $253.94, for a total transaction of $838,763.82. Following the completion of the transaction, the general counsel now owns 47,620 shares of the company’s stock, valued at approximately $12,092,622.80. The trade was a 6.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.79% of the company’s stock.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.